Mark Y. Chan, MBBS

Original Contribution

Sirolimus-Eluting, Bioabsorbable Polymer-Coated Constant Stent (Cura‚Ñ¢) in Acute ST-Elevation Myocardial Infarction: A Clinical a

08/01/2008

Jimmy Lim , MBBS;

Adrian F. Low , MD, MBBS;

Xiao-Ling Zhang , MD;

Than-Than Kyaing , MD;

Mark Y. Chan , MBBS;

Chi-Hang Lee , MD, MBBS, MRCP;

Huay-Cheem Tan , MBBS, MD;

Yean-Teng Lim , MBBS, MD;

Hwee Bee Wong , MSc, MD;

Drug-eluting stents (DES) have emerged as a novel technology in coronary revascularization. Ample evidence has shown that polymer-based DES effectively reduce in-stent restenosis and repeat revascularization after percutaneous coronary...

Drug-eluting stents (DES) have...

08/01/2008

Journal of Invasive Cardiology

Treatment of Very Small De Novo Coronary Artery Disease With 2.0 mm Drug-Coated Balloons Showed 1-Year Clinical Outcome Comparable With 2.0 mm Drug-Eluting Stents

04/15/2018

Chi-Hang Lee , MD, MBBS, MRCP;

Koo-Hui Chan , MD;

Joshua Loh , MD;

Hui Wen Sim , MBBS;

Huay-Cheem Tan , MBBS, MD;

Siew Pang Chan , PhD;

Mark Y. Chan , MBBS;

Edgar L. Tay , MBBS;

Poay Huan Loh , MBBS, MD;

Rajiv Ananthakrishna , MD, DM;

Adrian F. Low , MD, MBBS;

An evaluation of the 1-year clinical outcomes of patients treated with 2.0 mm drug-coated balloon vs 2.0 mm drug-eluting stent implantation in small-caliber vessel de novo coronary artery disease.

An evaluation of the 1-year...

04/15/2018

Journal of Invasive Cardiology